tyrosyl-isoleucyl-glycyl-seryl-arginine has been researched along with dipyridamole in 1 studies
Studies (tyrosyl-isoleucyl-glycyl-seryl-arginine) | Trials (tyrosyl-isoleucyl-glycyl-seryl-arginine) | Recent Studies (post-2010) (tyrosyl-isoleucyl-glycyl-seryl-arginine) | Studies (dipyridamole) | Trials (dipyridamole) | Recent Studies (post-2010) (dipyridamole) |
---|---|---|---|---|---|
111 | 0 | 29 | 7,826 | 881 | 632 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bracke, M; Bruyneel, E; De Mets, M; Mareel, M; Van Larebeke, N | 1 |
1 review(s) available for tyrosyl-isoleucyl-glycyl-seryl-arginine and dipyridamole
Article | Year |
---|---|
Invasion and metastasis control: implications for increased therapeutic index of antitumor drugs.
Topics: Antineoplastic Agents; Catechin; Dipyridamole; Glycoproteins; Humans; Microtubules; Neoplasm Invasiveness; Neoplasm Metastasis; Neoplasms; Oligopeptides; Phospholipid Ethers; Receptors, Immunologic; Receptors, Laminin | 1990 |